Fan Luo1, Jiaxin Cao2, Feiteng Lu2, Kangmei Zeng2, Wenjuan Ma3, Yan Huang2, Li Zhang4, Hongyun Zhao5. 1. Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, SunYat-Sen University Cancer Center, Guangzhou, China. 2. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China. 3. Department of Intensive Care Unit, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. 4. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China. zhangli6@mail.sysu.edu.cn. 5. Department of Clinical Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China. zhaohy@sysucc.org.cn.
Correction to: Cancer Cell Int (2021) 21:458 https://doi.org/10.1186/s12935-021-02162-w
In this article [1], the author would like to correct the two mistakes mentioned below with this erratum.In the methods section, “LAG-3 (1:200, ab101500, Abcam, Cambridge, MA)” should be changed to “LAG-3 (1:200, ab180187, Abcam, Cambridge, MA)”.In the Table 2 section, the title “Expression of LAG-3, PD-1, and PD-L1, CD3, GZMB in NSCLC patients” should be changed to “Expression of LAG-3, PD-1, and PD-L1, CD3, GZMB in NPC patients”. Correspondingly, “NSCLC: non-small cell lung cancer” should be changed to “NPC: nasopharyngeal carcinoma” in the caption of the table.